Benjamin Ory
Overview
Explore the profile of Benjamin Ory including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dupuy M, Postec A, Mullard M, Chantome A, Hulin P, Brion R, et al.
Cell Commun Signal
. 2024 Dec;
22(1):602.
PMID: 39695664
Background: Ewing sarcoma (ES), the second main pediatric bone sarcoma, is characterised by a chromosomal translocation leading to the formation of fusion proteins like EWS::FLI1. While several studies have shown...
2.
Dupuy M, Gueguinou M, Postec A, Brion R, Tesfaye R, Mullard M, et al.
Oncogene
. 2024 Nov;
44(2):79-91.
PMID: 39487324
Ewing sarcoma (ES) is characterized by EWS::FLI1 or EWS::ERG fusion proteins. Knowing that ion channels are involved in tumorigenesis, this work aimed to study the involvement of the KCNN1 gene,...
3.
Green D, Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, et al.
Clin Cancer Res
. 2024 Jun;
30(16):3395-3406.
PMID: 38869831
Osteosarcoma and Ewing sarcoma are bone tumors mostly diagnosed in children, adolescents, and young adults. Despite multimodal therapy, morbidity is high and survival rates remain low, especially in the metastatic...
4.
Lavaud M, Tesfaye R, Lassous L, Brounais B, Baudhuin M, Verrecchia F, et al.
Epigenomics
. 2024 Apr;
PMID: 38587919
Precise spatiotemporal regulations of gene expression are essential for determining cells' fates and functions. Enhancers are -acting DNA elements that act as periodic transcriptional thrusters and their activities are cell...
5.
Dupuy M, Lamoureux F, Mullard M, Postec A, Regnier L, Baudhuin M, et al.
Front Cell Dev Biol
. 2023 Sep;
11:1248753.
PMID: 37752913
In Europe, with an incidence of 7.5 cases per million, Ewing sarcoma (ES) is the second most common primary malignant bone tumor in children, adolescents and young adults, after osteosarcoma....
6.
Tesfaye R, Lavaud M, Charrier C, Brounais-Le Royer B, Cartron P, Verrecchia F, et al.
Environ Health Perspect
. 2023 Jun;
131(6):67007.
PMID: 37307168
Background: Osteoclasts are major actors in the maintenance of bone homeostasis. The full functional maturation of osteoclasts from monocyte lineage cells is essential for the degradation of old/damaged bone matrix....
7.
Rodriguez Calleja L, Lavaud M, Tesfaye R, Brounais-Le-Royer B, Baudhuin M, Georges S, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497429
TP53 (TP53), p73 (TP73), and p63 (TP63) are members of the p53 transcription factor family, which has many activities spanning from embryonic development through to tumor suppression. The utilization of...
8.
Moukengue B, Lallier M, Marchandet L, Baudhuin M, Verrecchia F, Ory B, et al.
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884563
Osteosarcoma (OS) is the most frequent primary bone tumor, mainly affecting children and young adults. Despite therapeutic advances, the 5-year survival rate is 70% but drastically decreases to 20-30% for...
9.
Morice S, Danieau G, Tesfaye R, Mullard M, Brion R, Dupuy M, et al.
Front Oncol
. 2021 Nov;
11:765711.
PMID: 34765560
Background: The poor survival rate of patients with osteosarcoma (OS), specifically with metastases at diagnosis, undergoes the urgency to develop new therapeutic strategies. Although we recently demonstrated the key role...
10.
Mullard M, Lavaud M, Regnier L, Tesfaye R, Ory B, Redini F, et al.
Biochem Pharmacol
. 2021 Oct;
194:114797.
PMID: 34678225
In children and young adults, primary malignant bone tumours are mainly composed of osteosarcoma and Ewing's sarcoma. Despite advances in treatments, nearly 40% of patients succumb to these diseases. In...